ASTROTECH Corp Increase Decrease In Operating Lease Liability
ASTROTECH Corp (ASTC) reported Increase Decrease In Operating Lease Liability of -$169.00 thousand for the 9-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- ASTROTECH Corp increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$65.00K.
- ASTROTECH Corp increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$90.00K.
- ASTROTECH Corp increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$14.00K.
- ASTROTECH Corp increase decrease in operating lease liability for the quarter ending 2025-06-30 was $288.00K.
- ASTROTECH Corp increase decrease in operating lease liability for fiscal 2025 was $170.00K.
- ASTROTECH Corp increase decrease in operating lease liability for fiscal 2024 was -$153.00K.
- ASTROTECH Corp increase decrease in operating lease liability for fiscal 2023 was -$130.00K.
- ASTROTECH Corp increase decrease in operating lease liability for fiscal 2022 was -$86.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$65.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-08-06 | -$155.00K derived: sum of 2 quarters · filed 2026-08-06 | -$169.00K 10-Q/A · filed 2026-08-06 | $119.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | -$104.00K 10-Q · filed 2026-02-13 | $184.00K derived: sum of 3 quarters · filed 2026-02-13 | $148.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | -$14.00K 10-Q · filed 2025-11-13 | $274.00K derived: sum of 2 quarters · filed 2025-11-13 | $238.00K derived: sum of 3 quarters · filed 2026-08-06 | $197.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $288.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-26 | $252.00K derived: sum of 2 quarters · filed 2026-08-06 | $211.00K derived: sum of 3 quarters · filed 2026-08-06 | $170.00K 10-K · filed 2025-09-26 |
| 2025-03-31 | -$36.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-08-06 | -$77.00K derived: sum of 2 quarters · filed 2026-08-06 | -$118.00K 10-Q/A · filed 2026-08-06 | -$158.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | -$41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | -$82.00K 10-Q · filed 2026-02-13 | -$122.00K derived: sum of 3 quarters · filed 2026-02-13 | -$161.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | -$41.00K 10-Q · filed 2025-11-13 | -$81.00K derived: sum of 2 quarters · filed 2025-11-13 | -$120.00K derived: sum of 3 quarters · filed 2025-11-13 | -$157.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | -$79.00K derived: sum of 2 quarters · filed 2025-09-26 | -$116.00K derived: sum of 3 quarters · filed 2025-09-26 | -$153.00K 10-K · filed 2025-09-26 |
| 2024-03-31 | -$39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | -$76.00K derived: sum of 2 quarters · filed 2025-05-14 | -$113.00K 10-Q · filed 2025-05-14 | -$157.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | -$74.00K 10-Q · filed 2025-02-14 | -$118.00K derived: sum of 3 quarters · filed 2025-02-14 | -$154.00K derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | -$37.00K 10-Q · filed 2024-11-13 | -$81.00K derived: sum of 2 quarters · filed 2024-11-13 | -$117.00K derived: sum of 3 quarters · filed 2024-11-13 | -$145.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20 | -$80.00K derived: sum of 2 quarters · filed 2024-09-20 | -$108.00K derived: sum of 3 quarters · filed 2024-09-20 | -$130.00K 10-K · filed 2024-09-20 |
| 2023-03-31 | -$36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | -$64.00K derived: sum of 2 quarters · filed 2024-05-14 | -$86.00K 10-Q · filed 2024-05-14 | |
| 2022-12-31 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | -$50.00K 10-Q · filed 2024-02-13 | ||
| 2022-09-30 | -$22.00K 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | -$86.00K 10-K · filed 2023-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |